- Home
- FULT vs CPRX Comparison
FULT vs CPRX Comparison
Compare FULT & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULT
- CPRX
- Stock Information
- Founded
- FULT 1882
- CPRX 2002
- Country
- FULT United States
- CPRX United States
- Employees
- FULT N/A
- CPRX N/A
- Industry
- FULT Major Banks
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- FULT Finance
- CPRX Health Care
- Exchange
- FULT Nasdaq
- CPRX Nasdaq
- Market Cap
- FULT 3.2B
- CPRX 2.6B
- IPO Year
- FULT N/A
- CPRX 2006
- Fundamental
- Price
- FULT $18.51
- CPRX $20.23
- Analyst Decision
- FULT Hold
- CPRX Strong Buy
- Analyst Count
- FULT 3
- CPRX 5
- Target Price
- FULT $20.67
- CPRX $33.20
- AVG Volume (30 Days)
- FULT 1.5M
- CPRX 1.4M
- Earning Date
- FULT 07-15-2025
- CPRX 08-06-2025
- Dividend Yield
- FULT 3.83%
- CPRX N/A
- EPS Growth
- FULT 1.58
- CPRX 183.96
- EPS
- FULT 1.71
- CPRX 1.65
- Revenue
- FULT $1,211,863,000.00
- CPRX $558,499,000.00
- Revenue This Year
- FULT N/A
- CPRX $16.37
- Revenue Next Year
- FULT $7.86
- CPRX $8.80
- P/E Ratio
- FULT $11.00
- CPRX $12.28
- Revenue Growth
- FULT 12.50
- CPRX 28.55
- 52 Week Low
- FULT $14.33
- CPRX $19.00
- 52 Week High
- FULT $22.49
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- FULT 52.96
- CPRX 42.27
- Support Level
- FULT $18.43
- CPRX $19.82
- Resistance Level
- FULT $17.88
- CPRX $20.51
- Average True Range (ATR)
- FULT 0.40
- CPRX 0.72
- MACD
- FULT 0.06
- CPRX -0.04
- Stochastic Oscillator
- FULT 78.48
- CPRX 31.95
About FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).